Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Injektionslösung in einer Fertigspritze
7680627190013
CH-62719
Injektionslösung
Associated product:
IBANDRONAT Mepha Osteo 3 mg/3ml i.v. ser prê 3 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
acidum ibandronicum
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii ibandronas monohydricus
|
- | Substance | WIZUS |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
12.53 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 62.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2014
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 62719
- Drug name
- Ibandronat-Mepha Osteo i.v., Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- M05BA06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 20/11/2013
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- IBANDRONAT Mepha Osteo 3 mg/3ml i.v. ser prê 3 ml
- Description (DE)
- IBANDRONAT Mepha Osteo 3 mg/3ml i.v. Fertspr 3 ml
- Market launch
- 20/11/2013
- Narcotic (BTM)
- No
Original drug
Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75